000 04875nam a22003975i 4500
999 _c393325
_d393325
001 393325
003 ES-MaUEC
005 20240217102712.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 100301s1998 xxu| fo |||| 0|eng d
020 _a9781592595730
024 7 _a10.1385/0896034380
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQP801. R47
_b1998 EB
245 0 0 _aRetinoid Protocols
_cedited by Christopher Redfern.
250 _a1st edition 1998
264 1 _aTotowa, NJ
_bHumana Press
_c1998
300 _a1 recurso en línea (XVI, 434 páginas)
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v89
505 0 _aHandling and Analysis of Retinoids -- Properties of Retinoids -- Quantitative Analyses of Naturally Occurring Retinoids -- Detection and Measurement of Retinoic Acid Production by Isolated Tissues Using Retinoic Acid-Sensitive Reporter Cell Lines -- Retinoid-Binding Proteins -- Immunohistochemistry for CRBPs and CRABPs -- Whole-Mount In Situ Hybridization of Mouse Embryos Exposed to Teratogenic Levels of Retinoic Acid -- Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for Cellular Retinoid-Binding Proteins -- Methods for Producing Recombinant Human Cellular Retinaldehyde-Binding Protein -- Expression and Purification of CRABPs from E. coli -- Purification and Fluorescent Titration of Cellular Retinol-Binding Protein -- Fluorometric Titration of the CRABPs -- Expression and Mutagenesis of Retinol-Binding Protein -- Interactions of Retinol-Binding Protein with Transthyretin and Its Receptor -- Detection of Conformational Changes in Cellular Retinoid-Binding Proteins by Limited Proteolysis -- Measurement of Rates of Dissociation of Retinoids from the Interphotoreceptor Retinoid-Binding Protein -- Use of Antisense Oligonucleotides to Study the Role of CRABPs in Retinoic Acid-Induced Gene Expression -- Nuclear Retinoid Receptors -- Preparation of Polyclonal Antibodies to Retinoid Receptors -- Detection of RARs and RXRs in Cells and Tissues Using Specific Ligand-Binding Assays and Ligand-Binding lmmunoprecipitation Techniques -- Nonisotopic In Situ Hybridization for the Detection of Nuclear Retinoid Receptor Transcripts in Tissue Sections -- In Situ Hybridization with 35S-Labeled Probes for Retinoid Receptors -- Isolation of Retinoid Receptors from Manimalian Cells -- Analysis of Retinoid Receptor Phosphorylation -- Photoaffinity Labeling of RARs and Mapping of Labeled Sites by an Endoproteinase Combination Technique -- PCR Cloning of N-Terminal RAR Isoforms and APL-Associated PLZF-RAR? Fusion Proteins -- RT-PCR in Diagnosis and Disease Monitoring of Acute Promyelocytic Leukemia (APL) -- A Two-Hybrid Protein Interaction System to Identify Factors That Interact with Retinoid and Vitamin D Receptors -- Gel-Shift Analysis and Identification of RXREs and RAREs by PCR-Based Selection -- Identification and Cloning of RA-Regulated Genes by mRNA-Differential Display -- Gene Targeting of Retinoid Receptors.
520 _aChristopher Redfern brings together in Retinoid Protocols a comprehensive collection of key biochemical and molecular methods for retinoid research. These easily reproducible techniques range from methods of handling and analyzing retinoids to advanced protocols for gene targeting, from binding protein function in transgenic animals to the study of nuclear retinoid receptors. In addition, the book makes accessible to all retinoid researchers such advanced techniques as cloning via RT-PCR, fluorimetry methods, recombinant protein purification and characterization, the use of antisense oligonucleotides to study the role of CRABPs, immunological and in situ hybridization methods, photoaffinity labeling, gel-shift analysis, and differential display. Many of the chapters in Retinoid Protocols represent landmarks in retinoid methodology because they give step-by-step instructions for techniques central to understanding cellular control by retinoids. These indispensable techniques will be fundamental for all those working with retinoids, and so will play a key role in the development of new drugs and therapies for treating human disease.
988 _aSpringer_Protocols_1998
650 7 _2embne
_9157930
_aRetinoides
776 0 8 _iPrinted edition:
_z9781489942449
776 0 8 _iPrinted edition:
_z9780896034389
776 0 8 _iPrinted edition:
_z9781489942432
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/0896034380
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b12/2023
_dz
_ean
_zSI